{"cluster": 45, "subcluster": 7, "abstract_summ": "In this review, we discuss how to appropriately identify high-risk patients for GIB and how to mitigate GIB risk with proton-pump inhibitor co-therapy, medication reconciliation, and Helicobacter pylori testing and treating in this complex and morbid population.With this changing practice, the authors suspect that inpatient gastrointestinal consult teams across the country will be frequently managing COVID-19 patients with gastrointestinal bleeding (GIB).Current evidence is insufficient to recommend routine pharmacological antithrombotic prophylaxis in all hospitalized patients with COVID-19.However, there is little international guidance on managing these risks in COVID-19 patients.In the era of COVID-19 pandemic is strongly recommended for patients who require chronic anticoagulation to continue therapy to prevent thromboembolic events.", "title_summ": "Guidance for anticoagulation management in venous thromboembolism during the coronavirus disease 2019 (COVID-19) pandemic in Poland: an expert opinion of the Section on Pulmonary Circulation of the Polish Cardiac Society.A Framework for Managing Anticoagulation-Related Gastrointestinal Bleeding in the Era of COVID-19Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far?The need to manage the risk of thromboembolism in COVID-19 patientsPPIs and Beyond:", "title_abstract_phrases": "With this changing practice, the authors suspect that inpatient gastrointestinal consult teams across the country will be frequently managing COVID-19 patients with gastrointestinal bleeding (GIB).However, there is little international guidance on managing these risks in COVID-19 patients.Current evidence is insufficient to recommend routine pharmacological antithrombotic prophylaxis in all hospitalized patients with COVID-19.In this review, we discuss how to appropriately identify high-risk patients for GIB and how to mitigate GIB risk with proton-pump inhibitor co-therapy, medication reconciliation, and Helicobacter pylori testing and treating in this complex and morbid population.In the era of COVID-19 pandemic is strongly recommended for patients who require chronic anticoagulation to continue therapy to prevent thromboembolic events."}